VAERS reports by lot

Moderna COVID-19 lot 003J21-2A: VAERS reports

86 VAERS reports list lot 003J21-2A as a Moderna COVID-19 vaccine, received between 2021-12-31 and 2023-06-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
86
Reports
19%
Marked serious
2
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5017%
Cardiac / Cardiovascular4817%
Neurological3713%
Gastrointestinal3111%
Dermatological (non-injection-site)3111%
Respiratory238%
Allergic / Anaphylactic217%
Injection-site / Local reaction186%
Musculoskeletal145%
Thrombotic / Hematological41%
Autoimmune / Immune-mediated41%
Psychiatric / Neuropsychiatric31%
Reproductive / Menstrual31%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York30
Texas6
South Carolina5
Michigan4
Kentucky4
Illinois3
Ohio3
Maine2
California2
Massachusetts2
Arizona2
Connecticut2

Reports by month received

2021-121
2022-0136
2022-0212
2022-0311
2022-048
2022-054
2022-063
2022-081
2022-092
2022-101
2022-122
2023-054
2023-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.